Summary
Prophylactic closure of the patent ductus arteriosus has been recommended as a means of decreasing the morbidity of the very low birth weight neonate. This study was undertaken in order to determine potential risk factors involved in the development of the silent ductus, its impact upon both the early cardiorespiratory symptomatology and the subsequent morbidity of the premature neonate, and finally the potential benefit to be derived from prophylatic closure in this presymptomatic stage.
Infants with birth weights of 1000 g or less were studied on days 2–3 of life echocardiographically, clinically, and with determination of plasma dilator prostaglandin levels. On entry to the study, those infants with early evidence of silent left-to-right patent ductus arteriosus (PDA) shunting were randomized to receive either prophylactic indomethacin or placebo therapy. Those infants with no evidence of ductal shunting were not treated at all.
Infants with silent PDAs had elevated levels of the dilator prostaglandin metabolite 6-keto PGF1α on admission, although they had no echocardiographic abnormalities. No other risk factors for PDA development could be identified. Silent PDA infants had an increased incidence of subsequent symptomatic PDAs, and overall morbidity and mortality when compared with those with no evidence of PDA (silent or symptomatic). Prophylactic ductal closure decreased the incidence of subsequent PDA development, but had no effect on overall morbidity and/or mortality.
Article PDF
Similar content being viewed by others
References
Allen H, Sahn D, Goldberg S (1978) New serial contrast techniques for assessment of left-to-right shunting patent ductus arteriosus in the neonate.Am J Cardiol 41:288–294
Brown E (1979) Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus.J Pediatr 95:865–866
Coker S, Clarke B, Zeitlin I (1982) Radioimmunoassay techniques for the determination of the local release of prostaglandins and thromboxanes.J Pharmacol Methods 7:207–217
Dudell G, Gersony W (1984) Patent ductus arteriosus in neonates with severe respiratory disease.J Pediatr 104:915–920
Edwards D, Jacob J, Gluck L (1980) The immature lung: radiographic appearance, course and complications.Am J Radiol 135:659–666
Ellison R, Peckham G, Lang P, Talner N, Lerer T, Lin L, Dooley K, Nadas A (1983) Evaluation of the preterm infant for patent ductus arteriosus.Pediatrics 71:364–372
Emmanouilides G (1977) Persistent patency of the ductus arteriosus in premature infants: incidence, perinatal factors and natural history. In:The 75th Ross conference on pediatric research. Ross Laboratories, Columbus OH
Fitzpatrick F, Gorman R, McGuire J, Kelly R, Wynalda M, Sun F (1977) A radioimmunoassay for thromboxane B2.Anal Biochem 82:1–7
Freidman Z, Demers L (1978) Essential fatty acid, prostaglandins and respiratory distress syndrome of the newborn.Pediatrics 61:341–347
Gersony W, Peckham G, Ellison R, Miettinen O, Nadas A (1983) Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.J Pediatr 102:895–906
Hammerman C, Strates E, Zaia W, Berger S, Aldousany A (1986) Prostaglandins and echocardiography in the assessment of the patent ductus arteriosus.Crit Care Med 14:462–465
Hirschfeld S, Meyer R, Schwartz D, Korfhagen J, Kaplan S (1975) Measurement of right and left ventricular systolic time intervals by echocardiography.Circulation 51:304–309
Jacob J, Gluck L, Di Sessa T, Edwards D, Kulovich M, Kurlinski J, Merritt T, Friedman W (1980) The contribution of PDA in the neonate with severe RDS.J Pediatr 96:79–87
Kaapa P, Lanning P, Kolvisto M (1983) Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome.Acta Paediatr Scand 72:179–184
Lucas M, Mitchell M (1978) Plasma prostaglandins in preterm neonates before and after treatment for patent ductus arteriosus. Lancet2:130–132
Mahoney L, Caldwell R, Girod D, Hurwitz R, Jansen R, Lemons J, Schreiner R (1985) Indomethacin therapy on the first day of life in infants with very low birth weight.J Pediatr 106:801–805
McGrath R, McGuiness G, Way G, Wolfe R, Nora J, Simmons M (1978) The silent ductus arteriosus.J Pediatr 93:110–113
Papile L, Burstein J, Burstein R, Koffler H (1978) Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 grams.J Pediatr 92:529–534
Silverman N, Lewis A, Heymann M, Rudolph A (1974) Echocardiographic assessment of ductus arteriosus shunt in premature infants.Circulation 50:821–825
Zednikova M, Baylen B, Yoshida Y, Emmanouilides G (1982) Precordial contrast echocardiographic detection of patent ductus arteriosus in small preterm infants.Pediatr Cardiol 2:271–275
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hammerman, C., Strates, E. & Valaitis, S. The silent ductus: Its precursors and its aftermath. Pediatr Cardiol 7, 121–127 (1986). https://doi.org/10.1007/BF02424985
Issue Date:
DOI: https://doi.org/10.1007/BF02424985